JP2007523087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523087A5 JP2007523087A5 JP2006553323A JP2006553323A JP2007523087A5 JP 2007523087 A5 JP2007523087 A5 JP 2007523087A5 JP 2006553323 A JP2006553323 A JP 2006553323A JP 2006553323 A JP2006553323 A JP 2006553323A JP 2007523087 A5 JP2007523087 A5 JP 2007523087A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- halo
- methyl
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 57
- -1 optionally Chemical group 0.000 claims 44
- 125000003545 alkoxy group Chemical group 0.000 claims 20
- 125000001475 halogen functional group Chemical group 0.000 claims 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 201000010099 disease Diseases 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 7
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 102000004311 liver X receptors Human genes 0.000 claims 4
- 108090000865 liver X receptors Proteins 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000006655 (C3-C8) heteroaryl group Chemical group 0.000 claims 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 230000007170 pathology Effects 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000005955 1H-indazolyl group Chemical group 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54414904P | 2004-02-11 | 2004-02-11 | |
| PCT/US2005/004652 WO2005077122A2 (en) | 2004-02-11 | 2005-02-11 | Compounds and compositions as lxr modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007523087A JP2007523087A (ja) | 2007-08-16 |
| JP2007523087A5 true JP2007523087A5 (enExample) | 2008-03-21 |
Family
ID=34860491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553323A Pending JP2007523087A (ja) | 2004-02-11 | 2005-02-11 | Ｌｘｒモジュレーターとしての化合物および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7846949B2 (enExample) |
| EP (1) | EP1713465A4 (enExample) |
| JP (1) | JP2007523087A (enExample) |
| CN (1) | CN1917870A (enExample) |
| AU (1) | AU2005211807C1 (enExample) |
| BR (1) | BRPI0507626A (enExample) |
| CA (1) | CA2553442A1 (enExample) |
| WO (1) | WO2005077122A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2872159B1 (fr) * | 2004-06-28 | 2007-10-05 | Merck Sante Soc Par Actions Si | Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| JP2008506702A (ja) | 2004-07-14 | 2008-03-06 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するための方法 |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| NZ553329A (en) | 2004-07-22 | 2010-09-30 | Ptc Therapeutics Inc | Thienopyridines for treating hepatitis C |
| CN101456863B (zh) * | 2007-12-14 | 2012-04-25 | 华北制药集团新药研究开发有限责任公司 | Lxr激动剂及其制备方法和用途 |
| US7786171B2 (en) * | 2008-04-04 | 2010-08-31 | Abbott Laboratories | Amide derivatives as positive allosteric modulators and methods of use thereof |
| AU2011299703A1 (en) | 2010-09-07 | 2013-04-11 | Snu R&Db Foundation | Sesterterpene compounds and use thereof |
| JP5674823B2 (ja) * | 2011-01-25 | 2015-02-25 | 三井化学アグロ株式会社 | 芳香族アミドカルボン酸誘導体の製造方法 |
| AU2015204572B2 (en) | 2014-01-10 | 2020-07-30 | Inspirna, Inc. | LXR agonists and uses thereof |
| JP7025022B2 (ja) | 2016-01-11 | 2022-02-24 | ザ ロックフェラー ユニバーシティー | 骨髄系由来抑制細胞関連障害の治療のための方法 |
| AU2018373028A1 (en) | 2017-11-21 | 2020-04-30 | Inspirna, Inc. | Polymorphs and uses thereof |
| PL3796975T3 (pl) | 2018-05-22 | 2024-02-26 | Orsobio, Inc. | Pochodne sulfonyloaminobenzamidu |
| TWI748194B (zh) * | 2018-06-28 | 2021-12-01 | 德商菲尼克斯 Ｆｘｒ有限責任公司 | 含有雙環核心部分之新穎lxr調節劑 |
| PL4073025T3 (pl) | 2019-12-13 | 2024-09-16 | Inspirna, Inc. | Sole metali i ich zastosowania |
| JP7555204B2 (ja) * | 2020-06-22 | 2024-09-24 | 東ソー株式会社 | 重合性化合物、重合体、光学薄膜 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1185194B (de) * | 1959-06-11 | 1965-01-14 | Nippon Shinyaku Co Ltd | Verfahren zur Herstellung von Abkoemmlingen des Salicylsaeureamides |
| CH480299A (fr) * | 1967-04-11 | 1969-10-31 | Sogespar S A | Procédé de préparation de dérivés des acides a-aminés N-disubstitués |
| CH516523A (fr) * | 1969-11-25 | 1971-12-15 | Sogespar S A | Procédé de préparation des dérivés des acides a-aminés N-disubstitués par benzoylation |
| LU78804A1 (de) * | 1977-12-30 | 1979-07-20 | Byk Gulden Lomberg Chem Fab | N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| JPS5683458A (en) * | 1979-12-10 | 1981-07-08 | Hodogaya Chem Co Ltd | Benzamide derivative and herbicide containing the same |
| GB8704671D0 (en) * | 1987-02-27 | 1987-04-01 | Shell Int Research | Glycine compounds |
| JPH07258224A (ja) | 1994-03-24 | 1995-10-09 | Dai Ichi Seiyaku Co Ltd | 二環性化合物 |
| US5438035A (en) * | 1994-06-24 | 1995-08-01 | American Cyanamid Company | Methods for controlling undesirable plant species with benzodiazepine compounds |
| JPH08143556A (ja) * | 1994-11-15 | 1996-06-04 | Terumo Corp | ジオキソチアゾリジン誘導体及びそれを含有する医薬組成物 |
| JPH111456A (ja) * | 1997-06-13 | 1999-01-06 | Otsuka Pharmaceut Co Ltd | アミド誘導体 |
| US6316503B1 (en) * | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
| KR20030045180A (ko) | 2000-11-10 | 2003-06-09 | 야마노우치세이야쿠 가부시키가이샤 | 아미드 유도체 |
| JP2005521721A (ja) * | 2002-03-27 | 2005-07-21 | スミスクライン・ビーチャム・コーポレイション | 酸およびエステル化合物ならびにその使用方法 |
| EP1509495A1 (en) * | 2002-05-24 | 2005-03-02 | Pharmacia Corporation | Anilino liver x-receptor modulators |
-
2005
- 2005-02-11 EP EP05723051A patent/EP1713465A4/en not_active Withdrawn
- 2005-02-11 US US10/589,410 patent/US7846949B2/en not_active Expired - Fee Related
- 2005-02-11 WO PCT/US2005/004652 patent/WO2005077122A2/en not_active Ceased
- 2005-02-11 JP JP2006553323A patent/JP2007523087A/ja active Pending
- 2005-02-11 CA CA002553442A patent/CA2553442A1/en not_active Abandoned
- 2005-02-11 BR BRPI0507626-9A patent/BRPI0507626A/pt not_active IP Right Cessation
- 2005-02-11 CN CNA2005800046748A patent/CN1917870A/zh active Pending
- 2005-02-11 AU AU2005211807A patent/AU2005211807C1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007523087A5 (enExample) | ||
| JP6955648B2 (ja) | 異常炎症反応に関連する状態を処置するための方法および組成物 | |
| KR20240039083A (ko) | 약제학적 제형 | |
| JP2011511806A5 (enExample) | ||
| JP2005518350A5 (enExample) | ||
| ES2282283T3 (es) | Derivados de bencilideno tiazolidinadionas y su uso como agentes antifungicos. | |
| JP2012525393A5 (enExample) | ||
| RU2013155586A (ru) | [1,3]оксазины | |
| JPH11503748A (ja) | サクシンアミド誘導体類と金属タンパク質分解酵素阻害剤としてのそれらの使用 | |
| JP2014532760A5 (enExample) | ||
| JPWO2005063704A1 (ja) | アゼチジン環化合物およびその医薬 | |
| TW200738698A (en) | Organic compounds | |
| JP2019518048A (ja) | がんの予防および／または治療のための化合物、組成物および方法 | |
| ES2353685T3 (es) | Derivados de tiazolidina y su uso como agente antifúngico. | |
| JP2006522025A (ja) | 炎症性疾患を治療するための新規な方法 | |
| JP2014510782A5 (enExample) | ||
| KR102336767B1 (ko) | 골수증식성 신생물 및 만성 골수성 백혈병을 포함하는, 트랜스듀신 β―유사 단백질 １（ＴＢＬ １） 활성과 관련된 질환 또는 장애의 치료 방법 | |
| JP2020520949A5 (enExample) | ||
| KR20210023984A (ko) | 헤테로환형 고리 및 아미노기로 치환된 피리딘 유도체 | |
| WO2007006534A3 (en) | Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity | |
| US20070167498A1 (en) | Carboxylic acid compounds | |
| RU2313524C2 (ru) | МИТИЛИНДОЛЫ И МЕТИЛПИРРОЛОПИРИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ α-1-АДРЕНЕРГИЧЕСКИХ АГОНИСТОВ | |
| JP6960415B2 (ja) | 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用 | |
| WO2014157158A1 (ja) | フェニル誘導体 | |
| JP2005526834A5 (enExample) |